Cat No.
NATE-0819
Description
CK-MB Type II possesses the naturally occurring carboxy-terminal amino acid lysine. This occurs during a myocardial infarct (MI or heart attack) when CK-MB Type II is released from damaged heart muscle, and the C-terminal lysine is cleaved in the blood stream, thus creating CK-MB Type I. This difference can be exploited in diagnosis of an MI.
Abbr
CKMBT2, Recombinant (Human)
Alias
CKMBT2; CKMBITII; CKMBII; CKMB
Source
Pichia Pastoris
Species
Human
Bio-activity
892 IU/mg
Appearance
Sterile Filtered colourless liquid formulation.
Purification
Greater than 95.0% as determined by (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.
Stability
CKMBITII although stable at 15°C for 7 days, should be stored below -18°C. Please prevent freeze-thaw cycles.
Synonyms
Creatine Kinase MB Isoenzyme Type-II; Creatine Kinase MB Isoenzyme Type-2; CKMBT2; CKMBITII; CKMBII; CKMB
